Track the Versartis, Inc. share price and the full insider trade history of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 1 February 2016 (Attribution). Among the most active insiders: Brumm Joshua T. Every trade is free.
6
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Versartis, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Versartis, Inc. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para trastornos endocrinos. Cotiza en NASDAQ bajo el símbolo VSAR.